Posted on 13/10/2025
FDA approval expands US access to award-winning lens technology Rayner today announced that the US Food and Drug Administration (FDA) has approved its RayOne EMV Toric intraocular lens (IOL) following the successful completion of a pivotal Investigational Device Exemption (IDE) study. The lens is now available to US surgeons seeking to deliver high quality visual
Posted on 15/09/2025
15 September 2025 | Worthing, UK The results of a landmark study comparing hydrophilic and hydrophobic intraocular lenses (IOLs), presented at the 2025 ESCRS Congress, has confirmed both IOL materials can be clinically and statistically equivalent in preventing posterior capsular opacification (PCO). The safety of hydrophilic IOLs compared to hydrophobic IOLs has been a subject
Posted on 6/05/2025
6 May 2025 Rayner, a global provider of solutions for cataract surgery and the only manufacturer of intraocular lenses (IOLs) in the UK, proudly announces today that it has been honoured with the prestigious King’s Award for Enterprise 2025 for its innovative RayOne EMV increased range of focus IOL. RayOne EMV, which launched in 2020,
Posted on 2/04/2025
02 April 2025 | In response to demand growth, Rayner – a global leader in solutions for cataract surgery – has completed an extensive expansion of its Worthing (UK) production facility, doubling the number of intraocular lenses (IOLs) it can manufacture annually to 4 million. Since opening its purpose-built manufacturing facility in 2017, every Rayner
Posted on 25/03/2025
In a major step toward redefining postoperative care and elevating patient experience, Rayner – a global leader in cataract surgery products – proudly announces the successful completion of its pivotal U.S. dropless cataract surgery study. OMIDRIA (phenylephrine and ketorolac intraocular solution 1% / 0.3%) is the only FDA-approved NSAID for use during cataract surgery, indicated
Posted on 3/02/2025
03.02.25 | Just 18 weeks on from the first implantation, Rayner is delighted to announce that it has now closed recruitment in the Investigational Device Exemption (IDE) study for the RayOne Galaxy intraocular lens in the USA. Developed in collaboration between Rayner, a global manufacturer of cataract surgery solutions, and ophthalmologist Dr João Lyra from
Posted on 23/01/2025
Mississauga, ON | 21 January 2025 Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is pleased to announce the approval of RayOne EMV Toric (RAO210T) by Health Canada. Developed in collaboration with Professor Graham Barrett, RayOne EMV and RayOne EMV Toric are the only patented aspheric IOLs that induce controlled
Posted on 15/01/2025
In September 2024, Rayner – a global manufacturer of products for cataract surgery based in the UK – unveiled the world’s first spiral IOL at the ESCRS congress in Barcelona. Today, following a large-scale multicentre data collection study, Rayner announces the full commercial release of RayOne Galaxy and RayOne Galaxy Toric, marking a wider global
Posted on 8/01/2025
Rayner, a global manufacturer of products for cataract surgery, today announces the launch of its redesigned online premium IOL calculator, RayTrace. One of the first online IOL calculation tools, RayTrace has been trusted by surgeons globally since 2008 for the accuracy of its premium IOL (toric, multifocal and supplementary) calculations, and has delivered over 360,000
Posted on 13/12/2024
Midland Eye, a private ophthalmology clinic based in Solihull, UK, were proud to become the first customer globally to receive the Sophi Phaco-emulsification machine following its acquisition by Rayner earlier this year. Worthing-based Rayner, a global manufacturer of products for cataract surgery, acquired Swiss-based This AG, the developer and manufacturer of Sophi, in January 2024.